Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

WuXi PharmaTech (Cayman) Beats on Both Top and Bottom Lines
Motley Fool
Saturday, May 12, 2012 - 12:31pm
tags:
WuXi PharmaTech, earnings
Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
Yahoo/PR NewsWire
Saturday, May 12, 2012 - 12:30pm
tags:
Stiefel Labs, Fabior Foam, acne
2 Strong Pharmaceuticals To Consider Now, 1 To Avoid
Seeking Alpha
Saturday, May 12, 2012 - 12:28pm
tags:
JNJ, Valeant Pharmaceuticals, Forest Labs
5 Fantastic Healthcare Dividends For The Income Investor
Seeking Alpha
Saturday, May 12, 2012 - 11:54am
tags:
Cardinal Health, HCP, JNJ, Merck, Pfizer
Sanofi Beats Analyst Estimates on EPS
Motley Fool
Saturday, May 12, 2012 - 11:52am
tags:
Sanofi, earnings
Standard Review for Biogen's BG-12
Yahoo/Zacks
Saturday, May 12, 2012 - 11:51am
tags:
Biogen Idec, BG-12, multiple sclerosis
5 Biotech Stocks At Rock Bottom Price With Takeover Possibility
Seeking Alpha
Saturday, May 12, 2012 - 11:27am
tags:
Chelsea Therapeutics, Oncothyreon, Keryx, ViroPharma, Spectrum Pharmaceuticals
Pfizer: Is 8 Really Enough?
Seeking Alpha
Saturday, May 12, 2012 - 11:26am
tags:
Pfizer, tofacitinib, rheumatoid arthritis
Let the Obesity-Drug Wars Begin
Motley Fool
Saturday, May 12, 2012 - 11:24am
tags:
Arena, Vivus, Orexigen, obesity, Contrave, Qnexa, lorcaserin, weight loss
Hostile Takeover? More Like Nice Guy Showdown.
Motley Fool
Saturday, May 12, 2012 - 11:22am
tags:
GSK, Human Genome Sciences, M&A
Osiris Therapeutics rises following 1Q results
Yahoo/AP
Saturday, May 12, 2012 - 11:20am
tags:
Osiris Therapeutics, earnings
Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer
Seeking Alpha
Saturday, May 12, 2012 - 11:19am
tags:
Threshold Pharmaceuticals, TH-302, cancer
Idenix Will Move Up On Promising New Data In 2013
Seeking Alpha
Saturday, May 12, 2012 - 11:17am
tags:
Idenix, IDX719, hepatitis C
Arena news boosts Orexigen, Vivus shares
Seeking Alpha
Saturday, May 12, 2012 - 11:16am
tags:
Arena Pharmaceuticals, Orexigen, Vivus, lorcaserin, Contrave, Qnexa, obesity, weight loss
Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'
Seeking Alpha
Friday, May 11, 2012 - 12:36pm
tags:
Watson Pharmaceuticals, JNJ, Novartis, Pfizer
Mylan launches generic Lipitor in France, U.K.
Marketwatch
Friday, May 11, 2012 - 12:30pm
tags:
Mylan, generics, Lipitor, France, UK
Pfizer Set To Surge On 3 New Drug Candidates
Seeking Alpha
Friday, May 11, 2012 - 12:22pm
tags:
Pfizer, Abbott Laboratories, Amgen, AstraZeneca, Watson Pharmaceuticals, JNJ, Bristol-Myers Squibb
Buy One, Get One Free at Charles River Laboratories
Yahoo/Morningstar
Friday, May 11, 2012 - 11:28am
tags:
Charles River Laboratories, CROs
Analysis And Valuation: J&J, Pfizer, Merck
Seeking Alpha
Friday, May 11, 2012 - 11:26am
tags:
JNJ, Merck, Pfizer
Endocyte Reports First Quarter 2012 Financial Results and Operations Update
Yahoo
Friday, May 11, 2012 - 11:24am
tags:
Endocyte, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.